Actively Recruiting
Preventing Chronification of Phantom Limb Pain Through Mirror Therapy in Conjunction With tDCS
Led by University of Haifa · Updated on 2025-09-08
108
Participants Needed
3
Research Sites
205 weeks
Total Duration
On this page
Sponsors
U
University of Haifa
Lead Sponsor
L
Loewenstein Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Background: Most amputees experience phantom limb pain (PLP), for years after amputation. Virtually all PLP research to date has focused on the mechanisms of chronic PLP, ignoring the mechanisms of chronification. This research project will focus on combined neuromodulatory interventions of mirror therapy (MT) and trans direct-cranial stimulation (tDCS), applied for the first time at the acute state of PLP, with an aim to prevent its chronification and chronicity. In PLP, maladaptive plasticity associated with sensory deafferentation following an amputation is one of the contributors for excessive pain. MT is a well-accepted yet limited option, which is thought to counterbalance abnormal plasticity. tDCS is an emerging approach believed to affect the membrane potential and activity threshold of cortical neurons. tDCS analgesic effectiveness, however, is mild and short, rendering it a noneffective stand-alone treatment. The researchers' objectives are to investigate whether the combined therapy of MT and tDCS will prevent chronic PLP and improve its related clinical characteristics. In addition, the researchers will investigate the behavioral manifestations effects of the combined treatment. The investigators expect that the combined treatment applied at the acute stage of PLP will have synergistic effects on PLP intensity and thus avert its chronification. In addition, it will reduce phantom sensations, and negative affect, and will improve the sense of body ownership and agency and endogenous inhibition efficiency. Research design: This randomized-controlled double-blinded study will be held at Israel's 3 largest rehabilitation centers. The study consists of 3 randomized patient arms (36 in each): (1) no-intervention, natural-course group; (2) MT + sham tDCS; (3) MT + real tDCS. MT and tDCS neuromodulatory interferences will be self-administered and consist of 20 sessions, completed during 4 weeks. The researchers outcome measures include: primary outcome: pain intensity, network-related behavioral markers, and amputation-related clinical characteristics. The data gathered will be collected at 5 timepoints. Research novelty and innovation: The researchers proposed model will provide insights on the prevention of PLP and, potentially, other neurological pathologies involving the dysfunction of sensory systems and integration and body perception.
CONDITIONS
Official Title
Preventing Chronification of Phantom Limb Pain Through Mirror Therapy in Conjunction With tDCS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Amputation of a single limb within the last 12 weeks
- Experiencing acute phantom limb pain for at least 2 weeks with pain intensity of 3 or higher on a 0-10 scale
- No changes in medication in the past week, except for occasional pain relief use
- Ability to understand the study purpose and instructions
- Willingness to provide written informed consent
You will not qualify if you...
- Unhealed stump wound
- Presence of other psychological, psychiatric, or neurological conditions
- Contraindications for tDCS or MRI, including previous seizure, head injury with loss of consciousness, metal in the head, implanted devices, claustrophobia, scalp skin conditions or wounds, and possibility of pregnancy
- Inability to provide informed consent or to understand and carry out study procedures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Loewenstein Hospital
Raanana, Israel, Israel, Ahuza 278
Actively Recruiting
2
Reut Medical Center
Tel Aviv, Israel, Israel
Actively Recruiting
3
Sheba Medical Center
Tel Aviv, Israel
Not Yet Recruiting
Research Team
R
Roi Treister, PhD
CONTACT
S
Shlomit Sorek, BPT MPT
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here